REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zdenpharm, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Zdenpharm, S.R.O. Profile Updated: July 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Zdenpharm, S.R.O. is an enterprise based in Slovakia. Its main office is in Nitra. It operates in the Pharmacies and Drug Stores sector. It was incorporated on March 23, 2006. It currently has a total number of 3 - 4 (2025) employees. The company’s latest financial report indicates a net sales revenue increase of 8.63% in 2025. Its’ total assets recorded a growth of 6.33%. In 2025, Zdenpharm, S.R.O.’s net profit margin decreased by 0.72%.

Headquarters
Hornocermanska 4
Nitra; Nitriansky; Postal Code: 94901

Contact Details: Purchase the Zdenpharm, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Zdenpharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Zdenpharm, S.R.O. report to view the information.
Financial Auditors:
Purchase the Zdenpharm, S.R.O. report to view the information.
Incorporation Date:
March 23, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Zdenpharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
8.63%▲
Total Operating Revenue
8.59%▲
Operating Profit
-4.06%▼
EBITDA
-3.53%▼
Net Profit/Loss for the Period
-6.54%▼
Total Assets
6.33%▲
Total Equity
14.2%▲
Operating Profit Margin
-0.69%▼
Net Profit Margin
-0.72%▼
Return on Equity (ROE)
-2.76%▼
Debt / Equity
-0.04%▼
Quick Ratio
11.86%▲
Cash Ratio
10.82%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo